{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:13:11Z","timestamp":1768464791427,"version":"3.49.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T00:00:00Z","timestamp":1435190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1004942","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T18:30:29Z","timestamp":1435257029000},"page":"e1004942","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis"],"prefix":"10.1371","volume":"11","author":[{"given":"Juan D.","family":"Unciti-Broceta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Maceira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Ortiz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Quero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Mu\u00f1\u00f3z-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry P.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Magez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Garcia-Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,25]]},"reference":[{"issue":"9394","key":"ref1","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"MP Barrett","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.idc.2012.03.003","article-title":"Human african trypanosomiasis","volume":"26","author":"R Brun","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"ref3","article-title":"Antigenic variation in African trypanosomes: the importance of chromosomal and nuclear context in VSG expression control","author":"L Glover","year":"2013","journal-title":"Cell Microbiol"},{"issue":"9683","key":"ref4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"issue":"1\u20132","key":"ref5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","article-title":"Drugs and drug resistance in African trypanosomiasis","volume":"10","author":"V Delespaux","year":"2007","journal-title":"Drug Resist Updat"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/molecules13102340","article-title":"Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems","volume":"13","author":"JL Arias","year":"2008","journal-title":"Molecules"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4155\/tde.13.87","article-title":"Novel therapy based on camelid nanobodies","volume":"4","author":"JD Unciti-Broceta","year":"2013","journal-title":"Therapeutic delivery"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1074\/jbc.M307341200","article-title":"Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm","volume":"279","author":"B Stijlemans","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nm1395","article-title":"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor","volume":"12","author":"TN Baral","year":"2006","journal-title":"Nat Med"},{"issue":"36","key":"ref10","doi-asserted-by":"crossref","first-page":"33458","DOI":"10.1074\/jbc.M103412200","article-title":"A conserved flagellar pocket exposed high mannose moiety is used by African trypanosomes as a host cytokine binding molecule","volume":"276","author":"S Magez","year":"2001","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2014.11.002","article-title":"Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis","volume":"197","author":"JL Arias","year":"2015","journal-title":"J Control Release"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1517\/17425247.2012.634794","article-title":"Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging","volume":"8","author":"JL Arias","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/bm101044h","article-title":"Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system","volume":"12","author":"JL Arias","year":"2011","journal-title":"Biomacromolecules"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.biomaterials.2012.10.013","article-title":"Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases","volume":"34","author":"M Malhotra","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejpb.2012.10.017","article-title":"Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules","volume":"83","author":"D Torrecilla","year":"2013","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2008.07.006","article-title":"Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis","volume":"108","author":"JK Thuita","year":"2008","journal-title":"Acta Trop"},{"issue":"7289","key":"ref17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"JA Frearson","year":"2010","journal-title":"Nature"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"e1002072","DOI":"10.1371\/journal.ppat.1002072","article-title":"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis","volume":"7","author":"B Stijlemans","year":"2011","journal-title":"PLoS Pathog"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"e1902","DOI":"10.1371\/journal.pntd.0001902","article-title":"Affinity is an important determinant of the anti-trypanosome activity of nanobodies","volume":"6","author":"G Caljon","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2859-11-23","article-title":"Expression and extracellular release of a functional anti-trypanosome Nanobody(R) in Sodalis glossinidius, a bacterial symbiont of the tsetse fly","volume":"11","author":"L De Vooght","year":"2012","journal-title":"Microb Cell Fact"},{"issue":"20","key":"ref21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0960-9822(00)80018-4","article-title":"N-linked glycans containing linear poly-N-acetyllactosamine as sorting signals in endocytosis in Trypanosoma brucei","volume":"9","author":"DP Nolan","year":"1999","journal-title":"Curr Biol"},{"issue":"7384","key":"ref22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"S Alsford","year":"2012","journal-title":"Nature"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ijpara.2007.05.007","article-title":"Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance","volume":"37","author":"SC Bernhard","year":"2007","journal-title":"Int J Parasitol"},{"issue":"47","key":"ref24","doi-asserted-by":"crossref","first-page":"28153","DOI":"10.1074\/jbc.270.47.28153","article-title":"Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and-resistant Trypanosoma brucei brucei","volume":"270","author":"NS Carter","year":"1995","journal-title":"J Biol Chem"},{"key":"ref25","article-title":"Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes","author":"N Baker","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/mol.106.031351","article-title":"Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes","volume":"71","author":"DJ Bridges","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"e2475","DOI":"10.1371\/journal.pntd.0002475","article-title":"Aquaporin 2 Mutations in <italic>Trypanosoma brucei gambiense<\/italic> Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol","volume":"7","author":"FE Graf","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","author":"JC Munday","year":"2013","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/AAC.48.5.1515-1519.2004","article-title":"The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes","volume":"48","author":"HP de Koning","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpddr.2013.01.004","article-title":"Functional expression of TcoAT1 reveals it to be a P1-type nucleoside transporter with no capacity for diminazene uptake","volume":"3","author":"JC Munday","year":"2013","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref31","article-title":"Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein","author":"JC Munday","year":"2015","journal-title":"Mol Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fphar.2015.00032","article-title":"Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei","volume":"6","author":"JC Munday","year":"2015","journal-title":"Front Pharmacol"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/fmb.11.88","article-title":"Drug resistance in human African trypanosomiasis","volume":"6","author":"MP Barrett","year":"2011","journal-title":"Future Microbiology"},{"key":"ref34","first-page":"217","article-title":"Trypanosomes and Trypanosomiasis","author":"J Garcia-Salcedo","year":"2014"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.coph.2012.05.001","article-title":"Antiparasitic agents: new drugs on the horizon","volume":"12","author":"P M\u00e4ser","year":"2012","journal-title":"Current Opinion in Pharmacology"},{"key":"ref36","article-title":"Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race","author":"M Vanaerschot","year":"2013","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"IM Vincent","year":"2010","journal-title":"PLoS Pathog"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molbiopara.2010.09.002","article-title":"Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters","volume":"175","author":"G Schumann Burkard","year":"2011","journal-title":"Mol Biochem Parasitol"},{"issue":"6408","key":"ref39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/361173a0","article-title":"Arsenical-resistant trypanosomes lack an unusual adenosine transporter","volume":"361","author":"NS Carter","year":"1993","journal-title":"Nature"},{"issue":"5425","key":"ref40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.285.5425.242","article-title":"A nucleoside transporter from Trypanosoma brucei involved in drug resistance","volume":"285","author":"P Maser","year":"1999","journal-title":"Science"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","article-title":"Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei","volume":"2","author":"E Matovu","year":"2003","journal-title":"Eukaryot Cell"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2009.10.003","article-title":"Targeted delivery of low molecular drugs using chitosan and its derivatives","volume":"62","author":"JH Park","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1\u20132","key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.12.026","article-title":"Chitosan microspheres as a potential carrier for drugs","volume":"274","author":"VR Sinha","year":"2004","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.colsurfb.2008.08.010","article-title":"Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles","volume":"67","author":"ML Manca","year":"2008","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0020-7519(97)00124-0","article-title":"Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model","volume":"27","author":"R Durand","year":"1997","journal-title":"International Journal for Parasitology"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1051\/parasite\/1994014319","article-title":"Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model","volume":"1","author":"T Fusai","year":"1994","journal-title":"Parasite (Paris, France)"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1051\/parasite\/1997044331","article-title":"Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model","volume":"4","author":"R Durand","year":"1997","journal-title":"Parasite"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"H Hirumi","year":"1989","journal-title":"The Journal of parasitology"},{"issue":"32","key":"ref49","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1016\/j.biomaterials.2010.07.067","article-title":"The influence of size and charge of chitosan\/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility","volume":"31","author":"BC Dash","year":"2010","journal-title":"Biomaterials"},{"key":"ref50","article-title":"Nicotinamide inhibits the lysosomal cathepsin b-like protease and kills African trypanosomes","author":"JD Unciti-Broceta","year":"2013","journal-title":"J Biol Chem"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"e61646","DOI":"10.1371\/journal.pone.0061646","article-title":"Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice","volume":"8","author":"IC Kourtis","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/EC.00200-09","article-title":"Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes","volume":"9","author":"ML Stewart","year":"2010","journal-title":"Eukaryot Cell"},{"issue":"23","key":"ref53","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1111\/j.1742-4658.2009.07432.x","article-title":"Alanine aminotransferase of Trypanosoma brucei\u2014a key role in proline metabolism in procyclic life forms","volume":"276","author":"D Spitznagel","year":"2009","journal-title":"FEBS J"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1004942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:46:01Z","timestamp":1589039161000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1004942"}},"subtitle":[],"editor":[{"given":"Jayne","family":"Raper","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,25]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1004942","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,25]]}}}